Pimentel Quezada, Yesenia <br/><br/>
Has the clinical profile of patients with nonvalvular atrial fibrillation treated with rivaroxaban changed in the last 5 years of use?  [electronic resource] 

 -  Future cardiology  05 2018 
 - 47-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-8298 
<br/><br/><label>Standard No.: </label>10.2217/fca-2018-0026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Atrial Fibrillation--complications<br/>Factor Xa Inhibitors--therapeutic use<br/>Female<br/>Hemorrhage--epidemiology<br/>Humans<br/>Male<br/>Patient Selection<br/>Practice Patterns, Physicians'<br/>Retrospective Studies<br/>Rivaroxaban--therapeutic use<br/>Stroke--etiology<br/>Treatment Outcome